PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

1,1 –Dimetylohydrazyna. Dokumentacja proponowanych wartości dopuszczalnych poziomów narażenia zawodowego

Autorzy
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
EN
1,1 Dimethylhvdrazine
Języki publikacji
PL
Abstrakty
PL
1,1 - Dimetylohydrazyna (UDMH) jest bezbarwną cieczą o zapachu amoniaku. Stosowana jest jako komponent płynnych paliw rakietowych, absorbent kwaśnych gazów, substancja redukująca oraz półprodukt w syntezie organicznej. Narażenie na ten związek występuje podczas magazynowania, transportu i stosowania substancji. Dane na temat toksyczności UDMH u ludzi są niewystarczające. Ostra toksyczność u zwierząt klasyfikuje ten związek do grupy substancji szkodliwych. W warunkach narażenia powtarzanego UDMH działa diuretycznie, immunosupresyjnie, hemolitycznie, pobudzająco lub depresyjnie na ośrodkowy i obwodowy układ nerwowy, a także hepatotoksycznie, nefrotoksycznie i rakotwórczo. Ponadto związek ten wywiera działanie genotoksyczne i mutagenne. W warunkach narażenia przewlekłego efektem krytycznym u psów jest niedokrwistość hemolityczna. Wartość NDS 1,1 -dimetylohydrazyny obliczono na podstawie wyznaczonego doświadczalnie najniższego obserwowanego poziomu działania szkodliwego (LOAEL), wynoszącego 12 mg/m3. Zaproponowano przyjęcie wartości NDS na poziomie 0,1 mg/mJ wraz z oznakowaniem substancji literami Sk, co wskazuje na łatwe wchłanianie związku przez skórę. Nie znaleziono merytorycznych podstaw do zaproponowania wartości NDSCh i DSB 1,1-dimetylohydrazyny.
EN
1,1- Dimethylhydrazine (UDMH) is a colourless liquid with an ammonia odour. This compound is used as a component of racket fuels, absorbent of acidic gases, reducer, and an intermediate in organic synthesis. The acute toxicity of UDMH in animals qualifies this compound as a harmful substance. During repeated exposure UDMH exerted diuretic, immunosuppresive, hemolytic, depressive or exiciting, hepatotoxic, nephrotoxic, and car-cinogenic effects. Moreover, its genotoxic and mutagenic effects have been confirmed. The MAC value of 0,1 mg/m3 was estimated on the basis of the LOAEL value (12 mg/m3) obtained in experiments on dogs (24 weeks) and relevant uncertainty factors. Skin (Sk) notation is recommended.
Rocznik
Tom
Strony
157--173
Opis fizyczny
Bibliogr. 42 poz., tab.
Twórcy
autor
  • Collegium Medicum Uniwersytetu Jagiellońskiego 30-688 Kraków ul. Medyczna 9
Bibliografia
  • 1. ACGIH (1996) 1,1-Dimethylhydrazine. TLVs and other occupational exposure values. American Conference of Governmental Industrial Hygienists. Cincinnati 1-8.
  • 2. Back K.C., Carter V.L.Jr, Thomas A.A. (1977) Occupational hazards of missile operations with special regard to the hydrazine propellants, in JANNAF Working Group on safety and environmental protection-Minutes of April 10-11 Meeting - John F. Kennedy Space Center, Florida. Laurel, Md, Johns Hopkins University, Chemical Propulsion Information Agency, Applied Physics Laboratory pp 25-47 [cyt. za NIOSH 1978].
  • 3. Back K.C. i in. (1963) Absorption, distribution, and excretion of l,l-dimethylhydrazine (UDMH). Toxicol. Appl. Pharmacol . 5, 401-413.
  • 4. Back K., Thomas A. (1963) Pharmacology and toxicology of 1,l-dimethylhydrazine. Am. Ind. Hyg. Assoc. J. 24, 23-27 .
  • 5. Barth M.L., Geake C.L., Cornish H.H. (1967) 1,1-Dimethylhydrazine-induced diuresis. Toxicol. Appl. Pharmacol . 11, 26-34.
  • 6. Bauer R.M., Tarr M. J., Olsen R.G. (1990) Effect of 1,1-dimethylhydrazine on lymphoproliferation and interleukin 2 immunoregulatory function. Arch. Environ. Contam. Toxicol. 19, 148-153.
  • 7. O’Brien R.D., Kirkpatrick M., Miller P.S. (1964) Poisoning of the rat by hydrazine and alkylhydrazines. Toxicol. Appl. Pharmacol, 6, 371-377.
  • 8. Brusick D., Matheson D. (1976) Mutagenic evaluation of 1,l-dimethylhydrazine, methylhydrazine and n-phenyl-a-naphthylamine, paper No. 4 Springfield, Va, US Dept of Commerce, National Technical Information Service., s. 108-139 (NTIS AD AO 4 1973) [cyt. za NIOSH 1978].
  • 9. Cornish H,H,, Hartung R. (1969) The subacute toxicity of 1,1-dimethylhydrazine. Toxicol. Appl. Pharmacol . 15, 62-68.
  • 10. Craven P.A,, Neidig M., DeRubertis F.R. (1985) Fatty acid stimulated N-demethylation of 1,2-dimethylhydrazine and tetramethylhydrazineby rat colonic mucosa. Biochem. Pharmacol. 34, 3101-3106.
  • 11. Frazier D.E. Jr., Tarr M.J,, Olsen R.G. (1991) The in vitro and in vivo effects of l,l-dimethylhydrazine (UDMH) on murine lymphocyte subsets and IA antigen expression. Immunopharmacol. Immunotoxicol. 13, 25-46.
  • 12. Frazier D.E. Jr., Tarr M.J., Olsen R.G. (1992) Evaluation of murine lymphocyte membrane potential, intracellular free calcium, and interleukin-2 receptor expression upon exposure to 1 ,1-dimethylhydrazine. Toxicol. Lett. 61, 27 -37 .
  • 13. Greenhouse G. (1976) Evaluation of the teratogenic effects of hydrazine, methylhydrazine, and dimethylhydrazine on embryos of Xenopus laevis, the South African clawed tead. Teratology 13,167-I78.
  • 14. Haun C.C. (1967) Canine hepatotoxic response to the inhalation of l,l-dimethylhydrazine (UDMH) and l,l-dimethylhydrazine with dimethylnitrosamine (DMNA), paper No. 9. Springfield Va, Dept of Commerce, National Technical Information Service s. 188-192 (NTIS ADAO4 1973) [cyt. za NIOSH 1978].
  • 15. Hines R., Prough R.A. (1980) The characteńzation of an inhibitory complex formed with cytochrome P-450 and a metabolite of l,l-disubstituted hydrazines. J. Pharmacol. Exp. Ther.2I1, 80-86.
  • 16. IARC (L974) Monographs on the evaluation of carcinogenic risks to man. Vol. 4. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. Lyon, 137-147.
  • 17. IARC (1987) Monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs volumens 1 to 42. Suppl. 7.Lyon. 62.
  • 18. Jacobson K.H. i in. (1955) The acute toxicity of the vapors of some methylated hydrazine derivatives. Arch. Ind. Health 12, 609-616.
  • 19. Jeong J.Y., Kamino K. (1993) Lack of tumorigenic activity of l,l-dimethylhydrazine in Syrian golden hamsters treated by subcutaneous injection. Exp. Toxicol. Pathol. 45, 61-63.
  • 20. NIOSH, National Institute for Occupational Safety and Health (1978) Criteria for a recommended standard. Occupational Exposure to Hydrazines. DFIEW (NIOSH) Pub. No. 78-172, Washington, June 94-106.
  • 21. Parodi S. i in. (1981) DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res. 41, 1469-1482.
  • 22. Patrick R.L., Back K.C. (L965) Pathology and toxicology of repeated doses of hydrazine and 1,l-dimethylhydrazine in monkeys and rats. Ind. Med. Surg. 34, 430-435.
  • 23. Petersen P. i in. (1970) Examination of the liver in personnel working with liquid rocket propellant. Brit. J. Ind. Med. 27, 141-146.
  • 24. Prough R.A. (1973) The N-oxidation of alkylhydrazines catalyzed by the microsomal mixedfunction amine oxidase. Arch. Biochem. Biophys. 158, 442-444.
  • 25. Reed D.J. i in. (1963) Biochemical and pharmacological studies of 1,1-dimethyl-hydruzine. Springfield, Va, US Dept of Commerce National Technical Information Service 18 s. (MTS AD 431 216) [cyt. za NIOSH 1978].
  • 26. Reinhardt C.F., Brittelli M.R. (1981) 1,l-Dimethylhydrazine. [W]: Patt’'s Industrial hygiene and toxicology. [Red.] G.D. Clayton, F.E. Clayton. Wiley, Ed. 3th, New York, vol. 2A, 2801-2803.
  • 27. Rinehart W.E., Donati E., Green E.A. (1960) The subacute and chronic toxicity of 1,l-dimethylhydrazine vapor. Am. Ind. Hyg. Assoc . J. 21,207 -210.
  • 28. Roe F.J.C., Grant G.A., Millican D.M. (1961) Carcinogenicity of hydrazine and 1,l-dimethylhydrazine for mouse lung nature . 216, 375 -376.
  • 29. Rothberg S., Cope O.B. (1955) Toxicity studies on hydrazine, methylhydrazine, symmetrical dimethylhydrazine, unsymmetrical dimethylhydrazine and dimethylnitrosamine (U). Chemical Walfare Laboratories, report no.2027. Army Chemical Center, Edgewood, Md.US Army Chemical Corps Research and Development Command, Chemical Warfare Laboratories, Toxicology Divisions. 21[cyt. za NIOSH 1978].
  • 30. Rumsey D.W., Cesta R.P. (1970) Odor threshold levels for YDMH and NO2. Am. Ind. Hyg. Assoc. J.31,339-342.
  • 31. Runge-Morris M.A., Jacob S., Novak R.F. (1988) Characterization of hydrazinestimulated proteolysis in human erythrocytes. Toxicol. Appl. Pharmacol. 94, 414-426.
  • 32. Runge-Morris M.A., Wu N., Novak R.F. (1994) Hydrazine-mediated DNA damage: Role of hemoprotein, electron transport, and organic freeradicals. Toxicol. Appl. Pharmacol. 125, 123-132.
  • 33. Shimizu H, Hayashi K., Takemura N. (1978) Relationships between the mutagenic and carcinogenic effects of hydrazine derivatives. Jpn. J. Hyg. 33,414-485 [cyt. za NIOSH I978l.
  • 34. Shook B.S., Cowart O.H. (1957) Healt hazards associated with unsymmetrical dimethylhydrazine. Ind. Med. Surg.26, 333-336.
  • 35. Smith E.B., Clark D.A. (197I) Absorption of unsymmetrical dimethylhydrazine ([UDMH) through canine skin. Toxicol. Appl. Pharmacol. 18, 649-659.
  • 36.The condensed chemical dictionary. [Red.] G.G. Hawley (1975) ed. 8. Van Nostrand Reinhold Co., New York, s. 314, 451, 575-576, 681-682.
  • 37. Toth B. (1973) l,l-Dimethylhydrazine (unsymmetrical) carcinogenesis in mice- Light microscopic and ultrastructural studies on neoplastic blood vessels. J. Natl. Cancer Int. 50, 181-194.
  • 38. Toth B. (1977) The large bowel carcinogenic effects of hydrazines and related compounds occurring in nature and in the environment. Cancer 40, 2427-2431.
  • 39. Weeks M.H. i in. (1963) Vapor toxicity of UDMH in rats and dogs from short exposures. Am. Ind. Hyg. Assoc. J.24, 137-143.
  • 40. Wittkop J.A., Prough R.A, Reed D.J. (1969) Oxidative demethylation of N-methylhydrazines by rat liver microsomes. Arch. Biochem. Biophys. 134, 308-315.
  • 41. Wong E.T. (1966) Renal functional response to hydrazine and 1,1-dimethylhydrazine. Toxicol. Appl. Pharmacol. 8, 1-56.
  • 42. WyrobekA.J., London S.A. (1973) Effect of hydrazines on environmental toxicology. AMRL-TR-73-I25, s. 417-432. Aerospace Medical Research Laboratory, Wright Patterson Air Force Base OH [cyt. za ACGIH 1996].
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-ccb6b809-f637-4ec2-8b36-d9d84fcaab82
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.